Blaise S. Lippa, Ph.D.
Affiliations: | 2000 | Stanford University, Palo Alto, CA |
Area:
Organic, Organometallic, Bioorganic, and Medicinal ChemistryGoogle:
"Blaise Lippa"Mean distance: 7.91
Parents
Sign in to add mentor| Paul A. Wender | grad student | 2000 | Stanford | |
| (The design, synthesis and biological evaluation of the first totally synthetic bryostatin analogues.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang J, Yang Q, Romero JA, et al. (2015) Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors. Acs Medicinal Chemistry Letters. 6: 1080-5 |
| Freeman-Cook KD, Autry C, Borzillo G, et al. (2010) Design of selective, ATP-competitive inhibitors of Akt. Journal of Medicinal Chemistry. 53: 4615-22 |
| Freeman-Cook KD, Autry C, Borzillo G, et al. (2010) Corrections to Design of Selective, ATP-Competitive Inhibitors of Akt Journal of Medicinal Chemistry. 53: 5895-5895 |
| Lippa B, Pan G, Corbett M, et al. (2008) Synthesis and structure based optimization of novel Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 3359-63 |
| Lippa B, Kauffman GS, Arcari J, et al. (2007) The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 17: 3081-6 |
| Wender PA, Baryza JL, Bennett CE, et al. (2002) The practical synthesis of a novel and highly potent analogue of bryostatin. Journal of the American Chemical Society. 124: 13648-9 |
| Zhu Z, Lippa B, Drach JC, et al. (2000) Design, synthesis, and biological evaluation of tricyclic nucleosides (dimensional probes) as analogues of certain antiviral polyhalogenated benzimidazole ribonucleosides. Journal of Medicinal Chemistry. 43: 2430-7 |
| Wender PA, Lippa B. (2000) Synthesis and biological evaluation of bryostatin analogues: The role of the A-ring Tetrahedron Letters. 41: 1007-1011 |
| Wender PA, Hinkle KW, Koehler MF, et al. (1999) The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues. Medicinal Research Reviews. 19: 388-407 |
| Wender PA, Lippa B, Park CM, et al. (1999) Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes. Bioorganic & Medicinal Chemistry Letters. 9: 1687-90 |